Relevance of ISDS in IP Matters
With more and more trade being centered on the intellectual property, there has been increased inclusion of IPR related provisions and coverage in trade agreements between nations. The common clauses for protection of IP include fair and equitable treatment/ international standards, prohibition on performance requirements and investor-state dispute settlement. One of the earlier successful trade agreements that strengthened the protection of IP was NAFTA. NAFTA's IP provisions created the highest standard of protection and enforcement of IP. The agreement provided companies wishing to work in Canada, Mexico and USA with a means not only to protect their IP but also with better laws for doing business in general. Therefore, earlier the agreements tried to protect IP and stressed on providing national treatment to the citizens of member state. In earlier agreements, IP was not considered as an investment per se, however, the leaked investment chapter of TPP explicitly includes intellectual property in its definition of investment.
The definition of investment in the proposed TPP Investment chapter provides that "investment means every asset that an investor owns or controls, directly or indirectly, that has the characteristics of an investment, including such characteristics as the commitment of capital or other resources, the expectation of gain or profit, or the assumption of risk. Forms that an investment may take include-(g) intellectual property rights [which are conferred pursuant to domestic laws of each Party].
1 Further, Article 12.6.1 of the Draft TPP Investment Chapter requires that, as a minimum standard of treatment, "Each Party shall accord to cover investments treatment in accordance with customary international law, including fair and equitable treatment and full protection and security". Subparagraph 2(a) interprets "fair and equitable treatment" to include "the obligation not to deny justice in criminal, civil, or administrative adjudicatory proceedings in accordance with the principle of due process embodied in the principal legal systems of the world". The most elastic interpretations of this requirement suggests that the minimum standard of treatment protects all "reasonable expectations" for profits arising from the granting or even filing of IP claims of an investor even in the absence of direct representations. Some of the cases where ISDS was evoked by the multi-national companies against the government for protecting their IPR are mentioned below:
Philip Morris Cases in Australia and Uruguay
Objecting to the "single presentation ordinance" and "80% health warning requirement" issued by the government of Uruguay and implementation of advertising restrictions by Australia for tobacco products, Philip Morris initiated arbitration proceedings against the government of Uruguay and Australia in the year 2010 and 2011 respectively. The company argued that these laws violates multiple provisions of the Uruguay-Switzerland Bilateral Investment Treaty and of the Australia-Hong Kong Bilateral Investment Treaty which provides protection for investments made in these countries, including brands, intellectual property, and ongoing business enterprises.
In Uruguay, PMI argues that introduction of "Single Presentation" Ordinance regulation, restricts competition to the detriment of foreign investors as it prohibits sales of more than one variation of cigarettes under a single brand name. Also, the introduction of 80% Health Warning Requirement violates Uruguay's BIT agreement because it leaves virtually no space on the pack for the display of legally protected trademarks. PMI claims that these measures go beyond the tobacco regulations enacted in virtually every country and have not been shown to reduce smoking rates. Instead these restrictions could further promote the proliferation of black market cigarettes, which in 2009 amounted to nearly one in four of all tobacco products consumed in Uruguay. 4 In Australia, PMA argues that tobacco plain packaging measure constitutes an expropriation of its Australian investments in breach of Article 6 of the Hong Kong Agreement. The measure also breaches Australian government's commitment under Article 2(2) of the Hong Kong Agreement to accord fair and equitable treatment to Philip Morris Asia's investments. Philip Morris Asia further asserts that tobacco plain packaging constitutes an unreasonable and discriminatory measure and that Philip Morris Asia's investments have been deprived of full protection and security in breach of Article 2(2) of the Hong Kong Agreement. 5 As part of relief, PMA has asked the arbitration panel to suspend the law and award substantial compensation for the financial damage that plain packaging would cause by commoditizing the cigarette market in Australia.
Commenting on these cases, Philip Morris said: "The two regulations which are challenged in Uruguay, and the one challenged in Australia, arbitrarily and unjustifiably restrict legitimate businesses from using their brands and trademarks to sell their products. Building a brand is a long-term significant investment which these governments have severely damaged, despite their pledge under binding international treaties not to deprive investors of their property without fair compensation in return". 6 As a consequence of arbitration proceedings, in April 2011, the Australian Government formally declared that it would reject ISDS provisions in all its subsequent FTAs. This stance arises from globally trending cases, which attempt to "limit [states'] capacity to put health warnings or plain packaging requirements on tobacco products". 7 The implications of this latter action demonstrate the invasive power of arbitration tribunals and their capacity to undermine domestic law.
Upholding the plain packaging law imposed by the Australian government, the tribunal in the arbitration, based in Singapore, has issued a unanimous decision agreeing with Australia's position that it has no jurisdiction to hear Philip Morris's claim on 18 December 2015.
8 Even though it is a first case wherein a country was successfully able to defend its ordinance in an ISDS case, this case has a very little relevance as the outcome of this case entirely hinged on a procedural issue rather than on the merits of the case.
Philip Morris case adds to the list of cases brought about by the tobacco companies by making use of ISDS procedure "as an effective way to frame plain packaging as a legal issue divorced from health concerns". 9 If PM wins any of these cases, it would mean that in order to protect the IP of a foreign investor, a country has to modify or withhold its public health policy so that the rights of investor are safe guarded under the treaty, thus, complicate the emergence of any legislation or other reforms for public health. In a recent notice of arbitration from P.J. Reynolds against Canada, the company pointed to "illegal expropriation of a legally protected trademark" 4 which is progressively a common protective term interpreted under ISDS provisions.
Eli Lily v Canada
Faced by back to back invalidation of two of its pharmaceutical patents for Strattera and Zyprexa, based on judicial interpretations of the utility requirements contained in the Canadian patent statute, Eli Lily filed a Notice of Arbitration under NAFTA Chapter 11 against Canadian Government in November 2014. 10 Eli Lilly challenges the use of Promise doctrine which requires patent applications to support the claimed inventive promise made by the applicant to satisfy the utility requirement by court for invalidating its patents. It was argued that it is a judge made law which is not implemented anywhere else in the world which altered the legal framework governing its investments and violates its "most basic and legitimate expectations of a stable business and legal environment." Thus, it is disadvantageous for foreign nationals by making their patent vulnerable to be attacked by insisting on proof of utility and disclosure of evidence.
Lily further argues that Canada violated obligations not only under NAFTA, but also under TRIPS and PCT by allowing generic rivals to challenge patents without providing sufficient evidence of utility or usefulness; thereby reaping the economic benefits associated with Lily's investments. As a relief, Lily not only seeks the damages in tune of 500 million dollars but also a change in Canadian patent law by asking an intervention by the Parliament to limit the interpretation of the utility requirement by judges". 4 The Eli lily law suit provides an insight as to what would happen if intellectual property is treated as "investment". By allowing the evocation of ISDS in IP dispute, it would allow a single investor to challenge the domestic laws of the country if it hampers his welfare in any way. The Canada Government is free to introduce any utility standard which is in accordance with the international law. The fact is that even TRIPS itself incorporates certain "flexibilities" which aim to permit countries to use TRIPS-compatible norms in a manner that enables them to pursue their own public policies, either in specific fields like access to pharmaceutical products or protection of their biodiversity, or more generally, in establishing macroeconomic, institutional conditions that support economic development even in the face of ever-increasing transnational obligations.
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Impact of Introduction of ISDS in IP Matters
"Investor-state dispute settlement" (ISDS) proceedings began as limited exceptions to the general rule of state-to-state enforcement. ISDS regimes evolved from a customary international law right to compensation for the expropriation of property through nationalizations of foreign assets. Inclusion of ISDN provisions in BITS and FTAs is important when dealing with developing countries where local courts and substantive rights may not meet widely accepted global standards. 12 ISDS mechanisms can allow foreign claimants wronged under the agreement to take their claim directly to the international investment tribunal forum provided by the treaty, therefore avoiding the local, cumbersome, and often corrupt remedies of domestic courts.
However, the opponents of provision argue that ISDS is fundamentally flawed and violates the principle of "equality before law". It gives foreign investors the right to sue governments for compensation if laws, policies, court decisions or other actions interfere with expected profits from investments, even if these government actions are in accordance with the public interest. This could lead to companies suing governments for using TRIPS flexibilities to promote access to medicines.
The Eli lily case serves as a case study to examine the effects of treating intellectual property as "investment". The inclusion of IP as investment will provide a leeway to the big companies to enforce ISDS in cases wherein they feel that the country's law does not cater to their interest as reflected in the treaty. The inventors can make use of the loopholes provided in the treaty to create pressure on the government to change or modify their IP law.
TRIPS Agreement which deals with trade related aspects of IP, itself incorporates certain "flexibilities" which aims to permit countries to use TRIPScompatible norms in a manner that enable them to pursue their own public policies, either in specific fields like access to pharmaceutical products or protection of their biodiversity, or more generally, in establishing macroeconomic, institutional conditions that support economic development even in the face of ever-increasing transnational obligations.
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Therefore, inclusion of IP in investment context poses a serious threat to country's law making power by providing the opportunity to the foreign investor to object the laws that have been domestic public interest if it does not suit their requirements.
The Philip Morris cases highlight the conflict between IP law and public health. The two cases highlight how introduction of ISDS could affect the implementation of public health policy. If PM wins any of these cases, it would mean that in order to protect the IP of a foreign investor, a country has to modify or withhold its public health policy so that the rights of investor are safe guarded under the treaty. The win would also imply that any company that does not like the policy initiated by the government could initiate arbitration proceedings against the government by stating that it harms their profit which would thereby, complicate the emergence of any legislation or other reforms for public health.
Even though the arbitration tribunal has agreed with the Australian government that it had no jurisdiction to hear Phillip Morris arguments in this case, the fight is far from over, as the tribunal refused to provide the judgment based on the merits of the case.
In the past, we have also seen tobacco companies making use of ISDS procedure "as an effective way to frame plain packaging as a legal issue divorced from health concerns". 9 In a recent notice of arbitration from P.J. Reynolds against Canada, the company pointed to "illegal expropriation of a legally protected trademark" which is progressively a common protective term interpreted under ISDS provisions. In April 2011, the Australian Government formally declared it would reject ISDS provisions in all its subsequent FTAs. This stance arises from globally trending cases, which attempt to "limit [states'] capacity to put health warnings or plain packaging requirements on tobacco products". 4 The implications of this latter action demonstrate the invasive power of arbitration tribunals and their capacity to undermine domestic law.
The introduction of IP as an investment in trade agreements can have a much serious impact on the developing countries wherein the countries make special provisions in order to protect their own domestic industries. Take for example, in Indian context, if the trading countries are allowed to invoke the ISDS clause, it would hamper the generic industry widely wherein the big pharmaceuticals will drag the government into multiple arbitration proceedings challenging its compulsory license provision in the patent law. Furthermore, various countries' commitment under DOHA Declaration for "access to affordable medicine" for all could also be jeopardized.
Recently there were reports that the talks between Canada and Europe for Comprehensive Trade and Investment Agreement (CETA) were inconclusive wherein Canada in order to protect its public interest refused EU demands on investor-state dispute settlement (ISDS) and intellectual property rights provisions. Canada requested that arbitration procedures in certain intellectual property (IP) areas be excluded from the scope of the ISDS mechanism in CETA.
13
Conclusion
ISDS was introduced to confer a right to an investor to initiate dispute settlement proceedings against a foreign government in their own right under international law if the foreign government violates his rights as per the agreement entered between two states and not as a mechanism to prohibit the government of the host country to make laws in public interest. The inclusion of intellectual property investment under the purview of ISDS realm threatens to put country's law making capabilities at the whim and fancy of the foreign investors. It would grant more privilege to the foreign investors to question and refute the national laws created by the host country if they are not as per their requirement. The inclusion also poses serious threat to countries commitment under international declarations such as DOHA declaration, regarding providing access to affordable medicine. The provision also seems to override the flexibility in TRIPS agreement that allow countries to pursue their own public policies even in the face of ever-increasing transnational obligations. Therefore, unless the provisions of the trade agreement clearly excludes certain types of decision on IP in the scope of what can be considered as "expropriation" implementing ISDS in IP matters will not be a wise choice.
